Qiagen's stock plummets to 2019 lows as analyst outlooks diverge sharply
Qiagen N.V. shares have suffered sharp declines this week, falling 10.7% on Tuesday and another 1.2% on Wednesday. The drop follows concerns over weaker U.S. sales, declining demand, and broader geopolitical tensions. Analysts have since adjusted their outlooks, though opinions remain mixed on the stock’s future path. The steep decline wiped out gains made during the pandemic, pushing Qiagen’s share price back to levels last seen in November 2019. Year-to-date, the stock has lost 30.8% of its value, now trading at a forward price-to-earnings ratio of 15.
Analysts have responded with differing views. DZ Bank lowered its price target from €50 to €38 but kept a 'Buy' rating. Meanwhile, Jefferies maintained a more optimistic stance, holding a 'Buy' recommendation with a €59 target. Technical analysts suggest a move above €30 could spark a recovery, though immediate support now sits at €27.70. Further critical levels are marked at €25 and €23.18. The downturn follows a broader trend of volatility in the sector. Options Trader Expert, known for an 82% success rate on closed positions since October 2019, has not yet commented on Qiagen’s latest movement.
Qiagen’s stock now trades at multi-year lows, erasing gains from the pandemic period. With mixed analyst ratings and key technical levels in focus, investors are watching for signs of stabilisation. The next major support at €27.70 will be closely monitored in the coming sessions.
